Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature
Author(s): Paoletti Jim, Kaul Monica, Kloesel Lawson G
Issue: Jul/Aug 2007 - Hormone Replacement Therapy
View All Articles in Issue
Abstract: There are many misconceptions about the profession of pharmaceutical compounding and the preparation of bioidentical hormones used in hormone replacement therapy. These misconceptions are unfounded, because compounding is regulated by individual state boards of pharmacy, and compounded bioidentical hormones are prepared only when prescribed by a physician who has made a professional judgment in the interest of the patient. Physicians and the pharmacists who compound bioidentical hormones have not only the right but also the responsibility to be aware of current information published in the scientific literature concerning any prescribed medication.
Related Keywords: Jim Paoletti, RPh, Monica Kaul, RPh, Lawson G. Kloesel, RPh, BS Pharm, FIACP, bioidentical hormone replacement therapy, BHRT, literature review, estradiol, estriol, risk factors, cardiovascular disorders, heart disease, cancer, osteoporosis, bone loss, thrombosis, blood clots, stroke, vaginal atrophy, atrophic vaginitis, neuroprotection, nervous system
Related Categories: HRT, LEGAL, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, LITERATURE REVIEW, INFORMATION RESOURCES
Download in electronic PDF format for $35